Skip to content
Screener

Harvard Bioscience HBIO Q2 2026 earnings

Reported August 11, 2026 · Before market open

Revenue$22.7MBeat by $1.3M
EPS-$0.14Beat by $0.07
Revenue estimate$21.5M
EPS estimate-$0.21

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$21.8M
EPS estimate-$0.17

FAQ

When did Harvard Bioscience report Q2 2026 earnings?
Harvard Bioscience (HBIO) reported Q2 2026 earnings on August 11, 2026 before market open.
What were Harvard Bioscience's Q2 2026 revenue and EPS?
Harvard Bioscience reported revenue of $22.7M and eps of $-0.14 for Q2 2026.
Did Harvard Bioscience beat estimates in Q2 2026?
Revenue beat the consensus estimate of $21.5M by $1.3M. EPS beat the consensus estimate of $-0.21 by $0.07.
How did Harvard Bioscience's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.1% from $20.5M a year earlier and eps declined 1300.0% from $-0.01.
Where can I find Harvard Bioscience's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001171843-26-005405) and the 10-Q periodic report (0001171843-26-005425) directly on SEC EDGAR. The filing index links above go to sec.gov.